Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors

View More View Less
  • 1 Departments of Neurosurgery and Pathology, New York University Medical Center and Kaplan Comprehensive Cancer Center, New York, New York
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00
Print or Print + Online

✓ To characterize some of the genetic events underlying the development of glioblastoma multiforme, the authors analyzed 65 astrocytic tumors (seven pilocytic astrocytomas, eight astrocytomas, 16 anaplastic astrocytomas, and 34 glioblastomas multiforme) for loss of heterozygosity for chromosome 17p, loss of heterozygosity for chromosomes 10p and 10q, amplification of the epidermal growth factor receptor (EGFR) gene, and amplification of the oncogenes N-myc, c-myc, and N-ras using Southern blot analysis. Alterations of the p53 gene (positive immunostaining for p53 protein in tumors with or without p53 gene mutations) in these 65 tumors were analyzed previously. None of the 65 tumors showed amplification or rearrangement of N-myc, c-myc, or N-ras oncogenes.

The molecular analysis presented here demonstrates distinct variants of astrocytic tumors, with at least three genetic pathways leading to glioblastoma multiforme. One pathway was characterized by 43 astrocytomas with alterations in p53. Glioblastomas with p53 alterations may represent tumors that progress from lower-grade astrocytomas. This variant was more likely to show loss of chromosome 17p than tumors without p53 alterations (p < 0.04). Seventy-five percent of tumors with loss of one 17p allele demonstrated mutations in the p53 gene. Loss of chromosome 10 was associated with progression from anaplastic astrocytoma (13%) to glioblastoma (38%) (p < 0.04). Amplification of the EGFR gene was a rare (7%) but late event in tumor progression (p < 0.03). A second pathway was characterized by six astrocytomas without p53 alterations and may represent clinically de novo high-grade tumors. These tumors were more likely to show amplification of the EGFR gene (83%) than tumors with p53 alterations. Sixty percent of tumors with EGFR amplification also showed loss of chromosome 10; loss of chromosome 17p was infrequent in this variant. One or more alternative pathways were characterized by 16 astrocytomas without p53 alterations and with none of the genetic changes analyzed in this study. Glioblastomas are a heterogeneous group of tumors that may arise via multiple genetic pathways.

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00

Contributor Notes

Address reprint requests to: Elizabeth W. Newcomb, Ph.D., Department of Pathology and Kaplan Comprehensive Cancer Center, New York University Medical Center, Room MSB 533, 550 First Avenue, New York, New York 10016.
  • 1.

    Bigner SH, , Burger PC, & Wong AJ, et al: Gene amplification in malignant human gliomas: clinical and histopathologic aspects. J Neuropathol Exp Neurol 47:191205, 1988 Bigner SH, Burger PC, Wong AJ, et al: Gene amplification in malignant human gliomas: clinical and histopathologic aspects. J Neuropathol Exp Neurol 47:191–205, 1988

    • Search Google Scholar
    • Export Citation
  • 2.

    Bigner SH, , Mark J, & Burger PC, et al: Specific chromosomal abnormalities in malignant human gliomas. Cancer Res 48:405411, 1988 Bigner SH, Mark J, Burger PC, et al: Specific chromosomal abnormalities in malignant human gliomas. Cancer Res 48:405–411, 1988

    • Search Google Scholar
    • Export Citation
  • 3.

    Bruner JM, , Saya H, & Moser RP: Immunocytochemical detection of p53 in human gliomas. Mod Pathol 4:671674, 1991 Bruner JM, Saya H, Moser RP: Immunocytochemical detection of p53 in human gliomas. Mod Pathol 4:671–674, 1991

    • Search Google Scholar
    • Export Citation
  • 4.

    Chung RY, , Whaley J, & Kley N, et al: TP53 gene mutations and 17p deletions in human astrocytomas. Genes Chromosom Cancer 3:323331, 1991 Chung RY, Whaley J, Kley N, et al: TP53 gene mutations and 17p deletions in human astrocytomas. Genes Chromosom Cancer 3:323–331, 1991

    • Search Google Scholar
    • Export Citation
  • 5.

    Collins VP: Amplified genes in human gliomas. Semin Cancer Biol 4:2732, 1993 Collins VP: Amplified genes in human gliomas. Semin Cancer Biol 4:27–32, 1993

    • Search Google Scholar
    • Export Citation
  • 6.

    Ekstrand AJ, , James CD, & Cavenee WK, et al: Genes for epidermal growth factor receptor, transforming growth factor α, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Res 51:21642172, 1991 Ekstrand AJ, James CD, Cavenee WK, et al: Genes for epidermal growth factor receptor, transforming growth factor α, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Res 51:2164–2172, 1991

    • Search Google Scholar
    • Export Citation
  • 7.

    Frankel RH, , Bayona W, & Koslow M, et al: p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency. Cancer Res 52:14271433, 1992 Frankel RH, Bayona W, Koslow M, et al: p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency. Cancer Res 52:1427–1433, 1992

    • Search Google Scholar
    • Export Citation
  • 8.

    Fujimoto M, , Fults DW, & Thomas GA, et al: Loss of heterozygosity on chromosome 10 in human glioblastoma multiforme. Genomics 4:210214, 1989 Fujimoto M, Fults DW, Thomas GA, et al: Loss of heterozygosity on chromosome 10 in human glioblastoma multiforme. Genomics 4:210–214, 1989

    • Search Google Scholar
    • Export Citation
  • 9.

    Fujimoto M, , Sheridan PJ, & Sharp ZD, et al: Proto-oncogene analyses in brain tumors. J Neurosurg 70:910915, 1989 Fujimoto M, Sheridan PJ, Sharp ZD, et al: Proto-oncogene analyses in brain tumors. J Neurosurg 70:910–915, 1989

    • Search Google Scholar
    • Export Citation
  • 10.

    Fults D, , Brockmeyer D, & Tullous MW, et al: p53 mutations and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Cancer Res 52:674679, 1992 Fults D, Brockmeyer D, Tullous MW, et al: p53 mutations and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Cancer Res 52:674–679, 1992

    • Search Google Scholar
    • Export Citation
  • 11.

    Fults D, , Pedone CA, & Thomas GA, et al: Allelotype of human malignant astrocytoma. Cancer Res 50:57845789, 1990 Fults D, Pedone CA, Thomas GA, et al: Allelotype of human malignant astrocytoma. Cancer Res 50:5784–5789, 1990

    • Search Google Scholar
    • Export Citation
  • 12.

    Fults D, , Tippets RH, & Thomas GA, et al: Loss of heterozygosity for loci on chromosome 17p in human malignant astrocytoma. Cancer Res 49:65726577, 1989 Fults D, Tippets RH, Thomas GA, et al: Loss of heterozygosity for loci on chromosome 17p in human malignant astrocytoma. Cancer Res 49:6572–6577, 1989

    • Search Google Scholar
    • Export Citation
  • 13.

    Hollstein M, , Sidransky D, & Vogelstein B, et al: p53 mutations in human cancers. Science 253:4953, 1991 Hollstein M, Sidransky D, Vogelstein B, et al: p53 mutations in human cancers. Science 253:49–53, 1991

    • Search Google Scholar
    • Export Citation
  • 14.

    Hurtt MR, , Moossy J, & Donovan-Peluso M, et al: Amplification of epidermal growth factor receptor gene in gliomas: histopathology and prognosis. J Neuropathol Exp Neurol 51:8490, 1992 Hurtt MR, Moossy J, Donovan-Peluso M, et al: Amplification of epidermal growth factor receptor gene in gliomas: histopathology and prognosis. J Neuropathol Exp Neurol 51:84–90, 1992

    • Search Google Scholar
    • Export Citation
  • 15.

    James CD, , Carlbom E, & Dumanski JP, et al: Clonal genomic alterations in glioma malignancy stages. Cancer Res 48:55465551, 1988 James CD, Carlbom E, Dumanski JP, et al: Clonal genomic alterations in glioma malignancy stages. Cancer Res 48:5546–5551, 1988

    • Search Google Scholar
    • Export Citation
  • 16.

    James CD, , He J, & Carlbom E, et al: Chromosome 9 deletion mapping reveals interferon α and interferon β-1 gene deletions in human glial tumors. Cancer Res 51:16841688, 1991 James CD, He J, Carlbom E, et al: Chromosome 9 deletion mapping reveals interferon α and interferon β-1 gene deletions in human glial tumors. Cancer Res 51:1684–1688, 1991

    • Search Google Scholar
    • Export Citation
  • 17.

    Kinzler KW, , Bigner SH, & Bigner DD, et al: Identification of an amplified, highly expressed gene in human glioma. Science 236:7073, 1987 Kinzler KW, Bigner SH, Bigner DD, et al: Identification of an amplified, highly expressed gene in human glioma. Science 236:70–73, 1987

    • Search Google Scholar
    • Export Citation
  • 18.

    Kleihues P, , Burger PC, & Scheithauer BW: Histological Typing of Tumors of the Central Nervous System, ed 2. Berlin: Springer-Verlag, 1991 Kleihues P, Burger PC, Scheithauer BW: Histological Typing of Tumors of the Central Nervous System, ed 2. Berlin: Springer-Verlag, 1991

    • Search Google Scholar
    • Export Citation
  • 19.

    Kornblith PL, , Walker MD, & Cassady JR: Neurologic Oncology. Philadelphia: JB Lippincott, 1987, pp 3548 Kornblith PL, Walker MD, Cassady JR: Neurologic Oncology. Philadelphia: JB Lippincott, 1987, pp 35–48

    • Search Google Scholar
    • Export Citation
  • 20.

    Lane DP: p53, guardian of the genome. Nature 358:1517, 1992 Lane DP: p53, guardian of the genome. Nature 358:15–17, 1992

  • 21.

    Lang FF, , Miller DC, & Pisharody S, et al: High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas. Oncogene 9:949954, 1994 Lang FF, Miller DC, Pisharody S, et al: High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas. Oncogene 9:949–954, 1994

    • Search Google Scholar
    • Export Citation
  • 22.

    Leenstra S, , Troost D, & Westerveld A, et al: Molecular characterization of areas with low grade tumor or satellitosis in human malignant astrocytomas. Cancer Res 52:15681572, 1992 Leenstra S, Troost D, Westerveld A, et al: Molecular characterization of areas with low grade tumor or satellitosis in human malignant astrocytomas. Cancer Res 52:1568–1572, 1992

    • Search Google Scholar
    • Export Citation
  • 23.

    Levine AJ, , Momand J, & Finlay CA: The p53 tumour suppressor gene. Nature 351:453456, 1991 Levine AJ, Momand J, Finlay CA: The p53 tumour suppressor gene. Nature 351:453–456, 1991

    • Search Google Scholar
    • Export Citation
  • 24.

    Louis DN, , von Deimling A, & Chung RY, et al: Comparative study of p53 gene and protein alterations in human astrocytic tumors. J Neuropathol Exp Neurol 52:3138, 1993 Louis DN, von Deimling A, Chung RY, et al: Comparative study of p53 gene and protein alterations in human astrocytic tumors. J Neuropathol Exp Neurol 52:31–38, 1993

    • Search Google Scholar
    • Export Citation
  • 25.

    Mashiyama S, , Murakami Y, & Yoshimoto T, et al: Detection of p53 gene mutations in human brain tumours by single strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene 6:13131318, 1991 Mashiyama S, Murakami Y, Yoshimoto T, et al: Detection of p53 gene mutations in human brain tumours by single strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene 6:1313–1318, 1991

    • Search Google Scholar
    • Export Citation
  • 26.

    Newcomb EW, , Lang FF, & Miller DC, et al: p53 in Growth Control and Neoplasia. Zurich: Charles Rudolphe Brupbacker Foundation Symposium, 1993, pp 39.139.3 Newcomb EW, Lang FF, Miller DC, et al: p53 in Growth Control and Neoplasia. Zurich: Charles Rudolphe Brupbacker Foundation Symposium, 1993, pp 39.1–39.3

    • Search Google Scholar
    • Export Citation
  • 27.

    Newcomb EW, , Madonia WJ, & Pisharody S, et al: A correlative study of p53 protein alteration and p53 gene mutation in glioblastoma multiforme. Brain Pathol 3:229235, 1993 Newcomb EW, Madonia WJ, Pisharody S, et al: A correlative study of p53 protein alteration and p53 gene mutation in glioblastoma multiforme. Brain Pathol 3:229–235, 1993

    • Search Google Scholar
    • Export Citation
  • 28.

    Nigro JM, , Baker SJ, & Preisinger AC, et al: Mutations in the p53 gene occur in diverse human tumour types. Nature 342:705708, 1989 Nigro JM, Baker SJ, Preisinger AC, et al: Mutations in the p53 gene occur in diverse human tumour types. Nature 342:705–708, 1989

    • Search Google Scholar
    • Export Citation
  • 29.

    Okazaki H: Fundamentals of Neuropathology. Morphological Basis of Neurological Disorders, ed 2. New York: Igaku-Shoin Medical, 1989, pp 205207 Okazaki H: Fundamentals of Neuropathology. Morphological Basis of Neurological Disorders, ed 2. New York: Igaku-Shoin Medical, 1989, pp 205–207

    • Search Google Scholar
    • Export Citation
  • 30.

    Oliner JD, , Kinzler KW, & Meltzer PS, et al: Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358:8083, 1992 Oliner JD, Kinzler KW, Meltzer PS, et al: Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358:80–83, 1992

    • Search Google Scholar
    • Export Citation
  • 31.

    Olopade OI, , Jenkins RB, & Ransom DT, et al: Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas. Cancer Res 52:25232529, 1992 Olopade OI, Jenkins RB, Ransom DT, et al: Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas. Cancer Res 52:2523–2529, 1992

    • Search Google Scholar
    • Export Citation
  • 32.

    Ransom DT, , Ritland SR, & Moertel CA, et al: Correlation of cytogenetic analysis and loss of heterozygosity studies in human diffuse astrocytomas and mixed oligo-astrocytomas. Genes Chromosom Cancer 5:357374, 1992 Ransom DT, Ritland SR, Moertel CA, et al: Correlation of cytogenetic analysis and loss of heterozygosity studies in human diffuse astrocytomas and mixed oligo-astrocytomas. Genes Chromosom Cancer 5:357–374, 1992

    • Search Google Scholar
    • Export Citation
  • 33.

    Reifenberger G, , Liu L, & Ichimura K, et al: Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res 53:27362739, 1993 Reifenberger G, Liu L, Ichimura K, et al: Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res 53:2736–2739, 1993

    • Search Google Scholar
    • Export Citation
  • 34.

    Rubio MP, , von Deimling A, & Yandell DW, et al: Accumulation of wild type p53 protein in human astrocytomas. Cancer Res 53:34653467, 1993 Rubio MP, von Deimling A, Yandell DW, et al: Accumulation of wild type p53 protein in human astrocytomas. Cancer Res 53:3465–3467, 1993

    • Search Google Scholar
    • Export Citation
  • 35.

    Russell DS, & Rubinstein LJ: Pathology of Tumours of the Nervous System, ed 5. Baltimore: Williams & Wilkins, 1989, pp 129 226 129–132, 224–226 Russell DS, Rubinstein LJ: Pathology of Tumours of the Nervous System, ed 5. Baltimore: Williams & Wilkins, 1989, pp 129–132, 224–226

    • Search Google Scholar
    • Export Citation
  • 36.

    Sauceda R, , Ocadiz R, & Gutierrez AL, et al: Novel combination of c-myc and N-ras oncogene alteration in brain tumors. Mol Brain Res 3:123132, 1988 Sauceda R, Ocadiz R, Gutierrez AL, et al: Novel combination of c-myc and N-ras oncogene alteration in brain tumors. Mol Brain Res 3:123–132, 1988

    • Search Google Scholar
    • Export Citation
  • 37.

    Saxena A, , Clark WC, & Robertson JT, et al: Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytoma. Cancer Res 52:67166721, 1992 Saxena A, Clark WC, Robertson JT, et al: Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytoma. Cancer Res 52:6716–6721, 1992

    • Search Google Scholar
    • Export Citation
  • 38.

    Saylors RL III, , Sidransky D, & Friedman HS, et al: Infrequent p53 gene mutations in medulloblastomas. Cancer Res 51:47214723, 1991 Saylors RL III, Sidransky D, Friedman HS, et al: Infrequent p53 gene mutations in medulloblastomas. Cancer Res 51:4721–4723, 1991

    • Search Google Scholar
    • Export Citation
  • 39.

    Schwartz AM, & Ghatak NR: Malignant transformation of benign cerebellar astrocytoma. Cancer 65:333336, 1990 Schwartz AM, Ghatak NR: Malignant transformation of benign cerebellar astrocytoma. Cancer 65:333–336, 1990

    • Search Google Scholar
    • Export Citation
  • 40.

    Seemayer TA, & Cavanee WK: Molecular mechanisms of oncogenesis. Lab Invest 60:585599, 1989 Seemayer TA, Cavanee WK: Molecular mechanisms of oncogenesis. Lab Invest 60:585–599, 1989

    • Search Google Scholar
    • Export Citation
  • 41.

    Sidransky D, , Mikkelsen T, & Schwechheimer K, et al: Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature 355:846847, 1992 Sidransky D, Mikkelsen T, Schwechheimer K, et al: Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature 355:846–847, 1992

    • Search Google Scholar
    • Export Citation
  • 42.

    Szénásy J, & Slowik F: Prognosis of benign cerebellar astrocytomas in children. Childs Brain 10:3947, 1983 Szénásy J, Slowik F: Prognosis of benign cerebellar astrocytomas in children. Childs Brain 10:39–47, 1983

    • Search Google Scholar
    • Export Citation
  • 43.

    Trent J, , Meltzer P, & Rosenblum M, et al: Evidence for rearrangement, amplification, and expression of c-myc in a human glioblastoma. Proc Natl Acad Sci USA 83:470473, 1986 Trent J, Meltzer P, Rosenblum M, et al: Evidence for rearrangement, amplification, and expression of c-myc in a human glioblastoma. Proc Natl Acad Sci USA 83:470–473, 1986

    • Search Google Scholar
    • Export Citation
  • 44.

    Venter DJ, & Thomas DGT: Multiple sequential molecular abnormalities in the evolution of human gliomas. Br J Cancer 36:753757, 1991 Venter DJ, Thomas DGT: Multiple sequential molecular abnormalities in the evolution of human gliomas. Br J Cancer 36:753–757, 1991

    • Search Google Scholar
    • Export Citation
  • 45.

    Vogelstein B, & Kinzler KW: p53 function and dysfunction. Cell 70:523526, 1992 Vogelstein B, Kinzler KW: p53 function and dysfunction. Cell 70:523–526, 1992

    • Search Google Scholar
    • Export Citation
  • 46.

    von Deimling A, , Eibl RH, & Ohgaki H, et al: p53 mutations are associated with 17p allelic loss in grade II and III astrocytoma. Cancer Res 52:29872990, 1992 von Deimling A, Eibl RH, Ohgaki H, et al: p53 mutations are associated with 17p allelic loss in grade II and III astrocytoma. Cancer Res 52:2987–2990, 1992

    • Search Google Scholar
    • Export Citation
  • 47.

    von Deimling A, , Louis DN, & von Ammon K, et al: Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme. J Neurosurg 77:295301, 1992 von Deimling A, Louis DN, von Ammon K, et al: Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme. J Neurosurg 77:295–301, 1992

    • Search Google Scholar
    • Export Citation
  • 48.

    von Deimling A, , Louis DN, & von Ammon K, et al: Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas. Cancer Res 52:42774279, 1992 von Deimling A, Louis DN, von Ammon K, et al: Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas. Cancer Res 52:4277–4279, 1992

    • Search Google Scholar
    • Export Citation
  • 49.

    von Deimling A, , von Ammon K, & Schoenfeld D, et al: Subsets of glioblastoma multiforme defined by molecular genetic analysis. Brain Pathol 3:1926, 1993 von Deimling A, von Ammon K, Schoenfeld D, et al: Subsets of glioblastoma multiforme defined by molecular genetic analysis. Brain Pathol 3:19–26, 1993

    • Search Google Scholar
    • Export Citation
  • 50.

    Wasson JC, , Saylors RL III, & Zeltzer P, et al: Oncogene amplification in pediatric brain tumors. Cancer Res 50:29872990, 1990 Wasson JC, Saylors RL III, Zeltzer P, et al: Oncogene amplification in pediatric brain tumors. Cancer Res 50:2987–2990, 1990

    • Search Google Scholar
    • Export Citation
  • 51.

    Watanabe K, , Nagai M, & Wakai S, et al: Loss of constitutional heterozygosity in chromosome 10 in human glioblastoma. Acta Neuropathol 80:251254, 1990 Watanabe K, Nagai M, Wakai S, et al: Loss of constitutional heterozygosity in chromosome 10 in human glioblastoma. Acta Neuropathol 80:251–254, 1990

    • Search Google Scholar
    • Export Citation
  • 52.

    Wisoff HS, & Llena JF: Glioblastoma multiforme of the cerebellum five decades after irradiation of a cerebellar tumor. J Neurooncol 7:339344, 1989 Wisoff HS, Llena JF: Glioblastoma multiforme of the cerebellum five decades after irradiation of a cerebellar tumor. J Neurooncol 7:339–344, 1989

    • Search Google Scholar
    • Export Citation
  • 53.

    Wong AJ, , Bigner SH, & Bigner DD, et al: Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci USA 84:68996903, 1987 Wong AJ, Bigner SH, Bigner DD, et al: Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci USA 84:6899–6903, 1987

    • Search Google Scholar
    • Export Citation
  • 54.

    Yamazaki H, , Fukui Y, & Ueyama Y, et al: Amplification of the structurally and functionally altered epidermal growth factor receptor gene (c-erbB) in human brain tumors. Mol Cell Biol 8:18161820, 1988 Yamazaki H, Fukui Y, Ueyama Y, et al: Amplification of the structurally and functionally altered epidermal growth factor receptor gene (c-erbB) in human brain tumors. Mol Cell Biol 8:1816–1820, 1988

    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 602 220 8
Full Text Views 207 15 3
PDF Downloads 111 20 6
EPUB Downloads 0 0 0